Life ScienceCompany
Shenzhen Hepalink Pharmaceutical Group M&A Summary
Shenzhen Hepalink Pharmaceutical Group has acquired 3 companies. A total of 3 acquisitions came from private equity firms.
Shenzhen Hepalink Pharmaceutical Group’s largest acquisition to date was in 2014, when it acquired Scientific Protein Laboratories for $338M. Shenzhen Hepalink Pharmaceutical Group has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).
Shenzhen Hepalink Pharmaceutical Group Business Overview
Where is Shenzhen Hepalink Pharmaceutical Group headquartered?
Shenzhen Hepalink Pharmaceutical Group is headquartered in Shenzhen, China.
What is Shenzhen Hepalink Pharmaceutical Group’s revenue?
Shenzhen Hepalink Pharmaceutical Group disclosed revenue of 5,445M CNY for 2023 and 7,159M CNY for 2022.
How many employees does Shenzhen Hepalink Pharmaceutical Group have?
Shenzhen Hepalink Pharmaceutical Group has 2,080 employees.
What sector is Shenzhen Hepalink Pharmaceutical Group in?
Shenzhen Hepalink Pharmaceutical Group is a life science company.
When was Shenzhen Hepalink Pharmaceutical Group founded?
Shenzhen Hepalink Pharmaceutical Group was founded in 1998.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 3
- M&A Advisors 1